{"id":131,"date":"2025-05-01T16:21:40","date_gmt":"2025-05-01T16:21:40","guid":{"rendered":"https:\/\/reobserv.com\/?page_id=131"},"modified":"2026-04-26T10:25:16","modified_gmt":"2026-04-26T10:25:16","slug":"publications","status":"publish","type":"page","link":"https:\/\/reobserv.com\/index.php\/publications\/","title":{"rendered":"Portfolio"},"content":{"rendered":"\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.708), 1.3rem);\"><strong>EAS Lipid Registry of Africa (EAS-LIPRA)<\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.208), 1rem);\"><strong>Synopsis<\/strong> &#8211; <a href=\"https:\/\/eas-society.org\/collaborations-outreach\/lipra\/\" data-type=\"link\" data-id=\"https:\/\/eas-society.org\/collaborations-outreach\/lipra\/\">EAS-LIPRA<\/a> brought together investigators from multiple African countries with support from various regions of the Western world with an interest in dyslipidaemia, preventive cardiology and patient care. This registry is envisaged to expand its reach across Africa and broadly facilitate multiple lines of scientific inquiry in lipidology and preventive cardiology through multisite participation. The outputs of this work are expected to inform and help improve clinical practice in that underrepresented part of the world.<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/eas-society.org\/collaborations-outreach\/lipra\/\"><strong>Video presentation of project<\/strong><\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Publications<\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Lyons ARM, Raal FJ, Mansfield BS <em>et al<\/em>. Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey.<strong><em> ATHEROSCLEROSIS PLUS&nbsp;<\/em>2025;&nbsp;61:18-22.<\/strong>&nbsp;<a href=\"https:\/\/doi.org\/10.1016\/j.athplu.2025.05.003\">doi.org\/10.1016\/j.athplu.2025.05.003<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\"><strong><a href=\"https:\/\/eas-society.org\/collaborations\/lipra\/lipra-publications\/\">Video presentation of above article<\/a><\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Reda A, Lyons ARM, Zambon A <em>et al<\/em>. A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA). <strong><em>ATHEROSCLEROSIS PLUS<\/em> 2024; 58:46-50. <\/strong><a href=\"https:\/\/doi.org\/10.1016\/j.athplu.2024.10.002\">doi.org\/10.1016\/j.athplu.2024.10.002<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>EAS-LIPRA Newsletter (Editor)<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/eas-society.org\/wp-content\/uploads\/2025\/01\/EAS-LIPRA-Newsletter-Issue-1-2025-Jan.pdf\" data-type=\"link\" data-id=\"https:\/\/eas-society.org\/wp-content\/uploads\/2025\/01\/EAS-LIPRA-Newsletter-Issue-1-2025-Jan.pdf\">Issue 1<\/a>, January 2025<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/eas-society.org\/wp-content\/uploads\/2025\/06\/EAS-LIPRA-Newsletter-Issue-2-2025-Jun.pdf\" data-type=\"link\" data-id=\"https:\/\/eas-society.org\/wp-content\/uploads\/2025\/01\/EAS-LIPRA-Newsletter-Issue-1-2025-Jan.pdf\">Issue 2<\/a>, June 2025<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/eas-society.org\/wp-content\/uploads\/2026\/01\/EAS-LIPRA-Newsletter-Issue-3-2026-Jan.pdf\">Issue 3<\/a>, January 2026<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/eas-society.org\/wp-content\/uploads\/2026\/03\/EAS-LIPRA-Newsletter-Issue-4-2026-Mar.pdf\">Issue 4<\/a>, March 2026<\/p>\n\n\n\n<p class=\"has-small-font-size\"><a href=\"https:\/\/postoffice.eas-society.org\/subscription?f=oSOANJwdnLPnKDiq8KsOrLhSutTjNFLVvknuZdUQSfATEaM4892yHTh89203O0SJzNnP\" data-type=\"link\" data-id=\"https:\/\/postoffice.eas-society.org\/subscription?f=oSOANJwdnLPnKDiq8KsOrLhSutTjNFLVvknuZdUQSfATEaM4892yHTh89203O0SJzNnP\">Subscribe<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>International Committee Meetings<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Lyons ARM, on behalf of EAS-LIPRA. Executive &amp; Steering Committees Briefing: \u2018EAS-LIPRA Project Overview and Direction\u2019. EAS-LIPRA Closed Meeting at the <strong>EAS 93<sup>rd<\/sup> Congress, Glasgow, UK; 04-05-2025.<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Lyons ARM, on behalf of EAS-LIPRA. Executive &amp; Steering Committees Briefing: \u2018EAS-LIPRA Project Status 2024\u2019. EAS-LIPRA Closed Meeting at the <strong>EAS 92<sup>nd<\/sup> Congress, Lyon, France; 26-05-2024.<\/strong><\/p>\n\n\n\n<p class=\"has-base-color has-text-color has-link-color wp-elements-06ba60ab35174af4c81347a828783a25\">.<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.708), 1.3rem);\"><strong>EAS Lipid Clinic Network (EAS-LCN)<\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.208), 1rem);\"><strong>Synopsis <\/strong>&#8211; <a href=\"https:\/\/eas-society.org\/collaborations-outreach\/lcn\/\">EAS-LCN<\/a> is a collaboration with established lipid clinics, globally, to&nbsp;address the challenges in the management of dyslipidaemias through harmonisation of efforts via shared experiences and knowledge exchange to assess, inform, improve and disseminate standardised guidelines of practice.<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Educational Programmes<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Industry-sponsored, EAS lipidology on-demand course with an application in progress for CME accreditation (coordination). <em>Course live <a href=\"https:\/\/eas-society.org\/course\/eas-lpa-workshop\/\">online<\/a>.<\/em><\/p>\n\n\n\n<p class=\"has-small-font-size\">Industry-sponsored, EAS lipidology workshops (coordination) in UK, Italy &amp; Germany.<\/p>\n\n\n\n<p class=\"has-small-font-size\">International webinar series on the published 2025 updated ESC\/EAS dyslipidaemia guidelines (coordination) for Brazil, Georgia, Iraq, Norway, Uzbekistan, Bosnia &amp; Herzegovina, Luxembourg, Greece, Colombia, Kazakhstan, Pakistan, Japan, Argentina, Egypt, Spain, Portugal, Denmark, Lithuania, Russia.<\/p>\n\n\n\n<p class=\"has-small-font-size\">International webinar series on the published EAS systemic metabolic disease management consensus (coordination) for Brazil, Czech Republic, Estonia, Greece, Georgia, Iraq, Kazakhstan, Lithuania, Pakistan, Portugal, Romania, Russia, Uzbekistan.<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Publications<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Lipid clinic position paper (writing group coordination).<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Survey Research<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Industry-sponsored, cardiovascular and lipidology related surveys (x3) on the EAS-LCN (coordination).<\/p>\n\n\n\n<p class=\"has-base-color has-text-color has-link-color wp-elements-06ba60ab35174af4c81347a828783a25\">.<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.708), 1.3rem);\"><strong>Industry-Sponsored Public Health Research <\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Written Report to Sponsor<\/strong><\/p>\n\n\n\n<p class=\"has-small-font-size\">Global distribution of cardiovascular disease risk factors in an international cohort that attended the EAS health check booth from 5<sup>th<\/sup>&nbsp;\u2013 7<sup>th<\/sup>&nbsp;May 2025. <\/p>\n\n\n\n<p class=\"has-base-2-color has-text-color has-link-color wp-elements-41aa29641d7c375b0175190ef78ade3b\">.<\/p>\n\n\n\n<p class=\"has-large-font-size\"><strong>Independent Portfolios of Consultants <\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.708), 1.3rem);\"><strong>Dr. Alexander R.M. Lyons, Ph.D<\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.375), 1.1rem);\"><strong>Personal Publication Track-Record of Projects from Career History<\/strong><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Lyons ARM, Raal FJ, Mansfield BS <em>et al<\/em>. Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey.<strong><em> ATHEROSCLEROSIS PLUS&nbsp;<\/em>2025;&nbsp;61:18-22.<\/strong>&nbsp;<a href=\"https:\/\/doi.org\/10.1016\/j.athplu.2025.05.003\">doi.org\/10.1016\/j.athplu.2025.05.003<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Elshorbagy A, Vallejo-Vaz AJ, Barkas F <em>et al<\/em>. Global prevalence of overweight and obesity among children and adults with heterozygous familial hypercholesterolemia, and their associations with cardiovascular disease. <strong><em>EUROPEAN HEART JOURNAL<\/em> 2025; ehae791. <\/strong><a href=\"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehae791\/7933169\">doi.org\/10.1093\/eurheartj\/ehae791<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Reda A, Lyons ARM, Zambon A <em>et al<\/em>. A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA). <strong><em>ATHEROSCLEROSIS PLUS<\/em> 2024; 58:46-50. <\/strong><a href=\"https:\/\/doi.org\/10.1016\/j.athplu.2024.10.002\">doi.org\/10.1016\/j.athplu.2024.10.002<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">[*Equal contributions] Elshorbagy A*, Lyons ARM*, Vallejo-Vaz AJ <em>et al<\/em>. Association of BMI, lipid-lowering medication, and age with prevalence of diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study by the EAS FHSC. <strong><em>THE LANCET DIABETES &amp; ENDOCRINOLOGY<\/em><\/strong> <strong>2024; 12(11):811-823.<\/strong> <a href=\"https:\/\/doi.org\/10.1016\/S2213-8587(24)00221-3\">doi.org\/10.1016\/S2213-8587(24)00221-3<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Mulder JWCM, Tromp TR, Al-Khnifsawi M <em>et al<\/em>. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia. <strong><em>JAMA CARDIOLOGY<\/em><\/strong> <strong>2024; 9(4):313-322. <\/strong><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38353972\/\">doi.org\/10.1001\/jamacardio.2023.5597<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Lyons ARM, Stevens CAT, Dharmayat KI <em>et al<\/em>. Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia. <strong><em>INDIAN HEART JOURNAL<\/em> 2024; 76:S113-116. <\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0019483223001785?via%3Dihub\">doi.org\/10.1016\/j.ihj.2023.11.005<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Dharmayat KI, Vallejo-Vaz AJ, Stevens CAT <em>et al<\/em>. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. <strong><em>THE LANCET <\/em>2024; 403(10421):55-66. <\/strong><a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(23)01842-1\">doi.org\/10.1016\/S0140-6736(23)01842-1<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Stevens CAT, Lyons ARM, Dharmayat KI <em>et al<\/em>. Ensemble Machine Learning Methods in Screening Electronic Health Records: A Scoping Review. <strong><em>DIGITAL HEALTH<\/em> 2023; May 9;9:20552076231173225. <\/strong><a href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/20552076231173225\">doi.org\/10.1177\/20552076231173225<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Stevens CAT, Lyons ARM, Dharmayat KI <em>et al<\/em>. FindMyLipidClinic.com: A global directory of lipid clinics and patient organisations to improve dyslipidaemia care. <strong><em>EUROPEAN ATHEROSCLEROSIS JOURNAL <\/em>2022; 2:37-40. <\/strong><a href=\"https:\/\/doi.org\/10.56095\/eaj.v1i2.11\">doi.org\/10.56095\/eaj.v1i2.11<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Tromp TR, Hartgers ML, Hovingh GK <em>et al<\/em>. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. <strong><em>THE LANCET<\/em> 2022; 399(10326):719-728. <\/strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673621020018?via%3Dihub#fn1\">doi.org\/10.1016\/S0140-6736(21)02001-8<\/a><\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Vallejo-Vaz AJ, Stevens CAT, Lyons ARM <em>et al<\/em>. A global perspective on familial hypercholesterolaemia:&nbsp; a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). <strong><em>THE LANCET <\/em>2021; 398(10312):1663-1776. <\/strong><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)01122-3\/fulltext#%20\">doi.org\/10.1016\/S0140-6736(21)01122-3<\/a>&nbsp;<\/p>\n\n\n\n<p style=\"font-size:clamp(0.875rem, 0.875rem + ((1vw - 0.2rem) * 0.042), 0.9rem);\">Lyons, ARM. The Effect of Isokinetic Exercise on Biofluid Matrices as Measured by 1H NMR Spectroscopy. <strong><a href=\"https:\/\/uel-repository.worktribe.com\/output\/482708\/the-effect-of-isokinectic-exercise-on-biofluid-matrices-as-measured-by-1h-nmr-spectroscopy\">Ph.D THESIS<\/a><\/strong>, University of East London, London UK. 2016. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>EAS Lipid Registry of Africa (EAS-LIPRA) Synopsis &#8211; EAS-LIPRA brought together investigators from multiple African countries with support from various regions of the Western world with an interest in dyslipidaemia, preventive cardiology and patient care. This registry is envisaged to expand its reach across Africa and broadly facilitate multiple lines of scientific inquiry in lipidology [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-131","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/pages\/131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/comments?post=131"}],"version-history":[{"count":67,"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/pages\/131\/revisions"}],"predecessor-version":[{"id":448,"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/pages\/131\/revisions\/448"}],"wp:attachment":[{"href":"https:\/\/reobserv.com\/index.php\/wp-json\/wp\/v2\/media?parent=131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}